Michael Lee

2.5k total citations
35 papers, 282 citations indexed

About

Michael Lee is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Lee has authored 35 papers receiving a total of 282 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Surgery, 18 papers in Cardiology and Cardiovascular Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Lee's work include Coronary Interventions and Diagnostics (10 papers), Cardiac Valve Diseases and Treatments (8 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Michael Lee is often cited by papers focused on Coronary Interventions and Diagnostics (10 papers), Cardiac Valve Diseases and Treatments (8 papers) and Atrial Fibrillation Management and Outcomes (4 papers). Michael Lee collaborates with scholars based in China, United Kingdom and Australia. Michael Lee's co-authors include Arvind Shah, Melvin J. Tonkon, L. Masana, Barry Gumbiner, Darbie Maccubbin, Leon A. Simons, Johan Bennett, Bryan P. Yan, Amin Ariff Nuruddin and John Thornton and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Hypertension.

In The Last Decade

Michael Lee

30 papers receiving 277 citations

Peers

Michael Lee
Thomas Kleisli United States
Phillip Goodney United States
Neil Swanson United Kingdom
Hoang Thai United States
Seo Na Hong South Korea
Carlos A. Gongora United States
B.J. Gersh United States
Michael Lee
Citations per year, relative to Michael Lee Michael Lee (= 1×) peers Maria Huelsebeck

Countries citing papers authored by Michael Lee

Since Specialization
Citations

This map shows the geographic impact of Michael Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Lee more than expected).

Fields of papers citing papers by Michael Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Lee. The network helps show where Michael Lee may publish in the future.

Co-authorship network of co-authors of Michael Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Lee. A scholar is included among the top collaborators of Michael Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Lee. Michael Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Chi‐Ming, et al.. (2025). Cardiovascular-Kidney-Metabolic healthcare framework: Perspective from Hong Kong. Chinese Medical Journal. 138(17). 2054–2056.
2.
Wong, Ivan, et al.. (2024). Single-Access Impella-Assisted Sheathless Antegrade and Retrograde Interventions of CTO. JACC: Cardiovascular Interventions. 17(7). 945–946. 1 indexed citations
3.
Ong, Paul Jau Lueng, Chor Cheung Tam, Woong Chol Kang, et al.. (2024). Polymer free biolimus coated stents to treat acute ST‐elevation myocardial infarction in Asian patients. Catheterization and Cardiovascular Interventions. 104(7). 1406–1413. 1 indexed citations
4.
Chiang, Michael C., et al.. (2024). Cardiac Power Output Ratio: Novel Survival Predictor After Percutaneous Ventricular Assist Device in cardiogenic shock. ESC Heart Failure. 11(6). 3674–3686. 3 indexed citations
5.
Wijesuriya, Nadeev, Vishal Mehta, Sandra Howell, et al.. (2023). Cost‐effectiveness analysis of leadless cardiac resynchronization therapy. Journal of Cardiovascular Electrophysiology. 34(12). 2590–2598. 2 indexed citations
6.
Lee, Michael, et al.. (2023). PO-01-188 PREVALENCE AND OUTCOMES OF ARRHYTHMIAS IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA). Heart Rhythm. 20(5). S181–S181.
7.
Wong, Ivan, et al.. (2022). Complimentary Role of ICE and TEE During Transcatheter Edge-to-Edge Tricuspid Valve Repair With TriClip G4. JACC: Cardiovascular Interventions. 15(5). 562–563. 8 indexed citations
8.
Wong, Ivan, et al.. (2022). Simplified Pacing-Over-the-Wire Technique to Streamline TAVR With Sentinel Cerebral Protection Device. JACC: Cardiovascular Interventions. 16(2). 226–228. 1 indexed citations
9.
Bennett, Johan, Adrian Włodarczak, Piero Montorsi, et al.. (2022). TCT-61 Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting—24-Month Follow-up of the Full Cohort (2,066 subjects) of the BIOSOLVE-IV Registry. Journal of the American College of Cardiology. 80(12). B25–B25.
10.
Wong, Ivan, et al.. (2022). Neo-Commissural Alignment During Transcatheter Aortic Valve Replacement. JACC: Cardiovascular Interventions. 15(15). 1582–1584. 5 indexed citations
11.
Bennett, Johan, Adrian Włodarczak, Jan Torzewski, et al.. (2021). TCT-117 Performance and Safety of the Resorbable Magnesium Scaffold, Magmaris, in a Real-World Setting: Primary and Secondary Endpoint Analysis of the Full Cohort (2,066 Subjects) of the BIOSOLVE-IV Registry. Journal of the American College of Cardiology. 78(19). B49–B49. 1 indexed citations
13.
Verheye, Stefan, Adrian Włodarczak, Piero Montorsi, et al.. (2020). BIOSOLVE‐IV‐registry: Safety and performance of the Magmaris scaffold: 12‐month outcomes of the first cohort of 1,075 patients. Catheterization and Cardiovascular Interventions. 98(1). E1–E8. 58 indexed citations
15.
Verheye, Stefan, Adrian Włodarczak, Piero Montorsi, et al.. (2019). TCT-45 Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris, in a Real-World Setting: First Cohort Subjects at 12-Month Follow-Up of the BIOSOLVE-IV Registry. Journal of the American College of Cardiology. 74(13). B45–B45. 2 indexed citations
16.
Galli, Stefano, Stefan Verheye, Adrian Włodarczak, et al.. (2019). 500.01 Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real-World Setting - 12-Month Follow-Up of First 600 Subjects in Biosolve-IV Registry. JACC: Cardiovascular Interventions. 12(4). S39–S39. 2 indexed citations
17.
Weitz, Jeffrey I., Annelise Segers, Gary E. Raskob, et al.. (2019). Randomized phase 2 trial comparing JNJ‐9375, a thrombin‐directed antibody, with apixaban for prevention of venous thrombosis. Journal of Thrombosis and Haemostasis. 17(12). 2081–2088. 3 indexed citations
19.
Ko, Young‐Guk, Seungbong Han, Young Hak Kim, et al.. (2015). Predictors of Permanent Pacemaker Insertion Following Transcatheter Aortic Valve Replacement With the CoreValve Revalving System Based on Computed Tomography Analysis: An Asian Multicenter Registry Study.. PubMed. 27(7). 334–40. 12 indexed citations
20.
Simons, Leon A., Melvin J. Tonkon, L. Masana, et al.. (2004). Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome. Current Medical Research and Opinion. 20(9). 1437–1445. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026